Kanaph Therapeutics Inc
KOSDAQ:0082N0
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
K
|
Kanaph Therapeutics Inc
KOSDAQ:0082N0
|
KR |
|
G
|
Gree Inc
F:V3U
|
JP |
|
C
|
CSX Corp
XMUN:CXR
|
US |
|
D
|
Duckshin Housing Co Ltd
KOSDAQ:090410
|
KR |
|
M
|
MGX Resources Ltd
XMUN:FWQ
|
AU |
|
G
|
Gadsden Properties Inc
OTC:GADS
|
US |
|
P
|
POSaBIT Systems Corp
CNSX:PBIT
|
US |
|
I
|
Ingredion Inc
SWB:CNP
|
US |
|
T
|
Taylor Maritime Ltd
LSE:TMI
|
GG |
|
M
|
M-Power Information Co Ltd
TPEX:6874
|
TW |
|
Aryzta AG
OTC:ARZTY
|
CH |
|
D
|
Drax Group PLC
DUS:D9F2
|
UK |
|
A
|
Afrocentric Investment Corporation Ltd
JSE:ACT
|
ZA |
|
Neurones SA
F:NE9
|
FR |
|
Nu Holdings Ltd.
F:M1Z
|
BR |
|
Medlive Technology Co Ltd
HKEX:2192
|
CN |
|
E
|
Endeavour Silver Corp
NYSE:EXK
|
CA |
|
Plenti Group Ltd
ASX:PLT
|
AU |
|
Airtel Africa PLC
F:9AA0
|
UK |
|
DHT Holdings Inc
NYSE:DHT
|
BM |
|
S
|
SML Isuzu Ltd
BSE:505192
|
IN |
|
W
|
WW Grainger Inc
SWB:GWW
|
US |
|
Exxaro Resources Ltd
OTC:EXXAF
|
ZA |
|
N
|
Netweb Technologies India Ltd
BSE:543945
|
IN |
Bankruptcy Probability
Kanaph Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Kanaph Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| KR |
K
|
Kanaph Therapeutics Inc
KOSDAQ:0082N0
|
130.1B KRW |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
506.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
240.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
196.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
131.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
83.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
79.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
88.4B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
58.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
48.8B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
39.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Kanaph Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Kanaph Therapeutics Inc has total debt of 81.8m . This includes both short-term (0 ) and long-term (81.8m ) debt.
You can find a full breakdown on its Balance Sheet.